MedTrace Logo

Population Screening Using Smartphone in Milpa Alta

NCT04067063 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150000

Last updated 2020-07-07

No results posted yet for this study

Summary

The objective of this study is to make a suicide screening in the entire population of Milpa Alta (approximately 150,000 inhabitants), taking into account other outcomes such as depression, anxiety, alcohol and drugs. For this, an app for Smartphone (MeMind) or a web platform (www.MeMind.net) will be used in which the participants will take a self-administered questionnaire, composed of several psychometric instruments .

It is expected that 70% of the population between 15 and 70 years old can do so directly with their own Smartphone, although web access posts will be enabled in educational and municipal units to avoid discrimination based on age or access to technology.

Our main hypothesis argues that the early identification of people at risk in almost the entire community can be done with an App for Smartphone, serving to depict a map of mental health and related needs of the population, serving for the planning of healthcare services of the local environment, and ultimately for the best assistance of groups and individuals with greater needs through their identification and early reference to medical assistance.

Conditions

Interventions

OTHER

Self-administered evaluation questionnaire

Smartphone app with MeMind questionnaires

Sponsors & Collaborators

  • Universidad Nacional Autonoma de Mexico

    collaborator OTHER

  • Milpa Alta Municipalty

    collaborator UNKNOWN

  • Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

    collaborator OTHER_GOV

  • Centro Interdisciplinario de Ciencias de la Salud, Mexico

    collaborator UNKNOWN

  • Educational Institutions of Milpa Alta

    collaborator UNKNOWN

  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-26
Primary Completion
2021-01-23
Completion
2021-04-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04067063 on ClinicalTrials.gov